RE-BVS – Piemonte Repository

Sfoglia per AUTORE
TAVONI A
Collezione AOU Città della Salute di Torino

Items : 5

Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase. in Journal of translational autoimmunity / J Transl Autoimmun. 2023 Oct 9;7:100212. doi: 10.1016/j.jtauto.2023.100212. eCollection 2023 Dec.

2023
AOU Città della Salute di Torino

Ferri C; Raimondo V; Giuggioli D; Gragnani L; Lorini S; Dagna L; Bosello SL; Foti R; Riccieri V; Guiducci S; Cuomo G; Tavoni A; De Angelis R; Cacciapaglia F; Zanatta E; Cozzi F; Murdaca G; Cavazzana I; Romeo N; Codullo V; Pellegrini R; Varcasia G; De Santis M; Selmi C; Abignano G; Caminiti M; L'Andolina M; Olivo D; Lubrano E; et alii...

Spectrum of short-term inflammatory musculoskeletal manifestations after COVID-19 vaccine administration: a report of 66 cases. in Annals of the rheumatic diseases / Ann Rheum Dis. 2022 Mar;81(3):440-441. doi: 10.1136/annrheumdis-2021-221587. Epub 2021 Nov 26.

2022
AOU Città della Salute di Torino

Guiducci S; Dagna L; Fusaro E; Cuomo G; D'Onghia M; Brusi V; Mancarella L; Ciaffi J; Visentini M; De Luca G; Bruno C; Bilia S; De Santis M; Motta F; Campochiaro C; D'Angelo S; Tavoni A; Foti R; Francioso F; Galluccio F; Di Cola I; Olivo D; Pigatto E; Cacciapaglia F; De Angelis R; Raimondo V; Ursini F; Ruscitti P; Meliconi R; et alii...

Systemic syndromes of rheumatological interest with onset after COVID-19 vaccine administration: a report of 30 cases. in Clinical rheumatology / Clin Rheumatol. 2022 Jul;41(7):2261-2267. doi: 10.1007/s10067-022-06078-2. Epub 2022 Jan 29.

2022
AOU Città della Salute di Torino

Guiducci S; Dagna L; Cipriani P; Fusaro E; D'Onghia M; Cuomo G; Brusi V; Mancarella L; Ciaffi J; Visentini M; De Luca G; Bruno C; Bilia S; De Santis M; Motta F; Campochiaro C; D'Angelo S; Tavoni AG; Foti R; Francioso F; Galluccio F; Olivo D; Di Cola I; Cacciapaglia F; Pigatto E; De Angelis R; Raimondo V; Ursini F; Ruscitti P; et alii...

Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies. in Current pharmaceutical design / Curr Pharm Des. 2022;28(24):2022-2028. doi: 10.2174/1381612828666220614151732.

2022
AOU Città della Salute di Torino

Ferri C; Raimondo V; Gragnani L; Giuggioli D; Dagna L; Tavoni A; Ursini F; L'Andolina M; Caso F; Ruscitti P; Caminiti M; Foti R; Riccieri V; Guiducci S; Pellegrini R; Zanatta E; Varcasia G; Olivo D; Gigliotti P; Cuomo G; Murdaca G; Cecchetti R; De Angelis R; Romeo N; Ingegnoli F; Cozzi F; Codullo V; Cavazzana I; Colaci M; et alii...

Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments. in Current pharmaceutical design / Curr Pharm Des. 2021;27(41):4245-4252. doi: 10.2174/1381612827666210903103935.

2021
AOU Città della Salute di Torino

Ferri C; Giuggioli D; Raimondo V; L'Andolina M; Dagna L; Tavoni A; Caso F; Ursini F; Ruscitti P; Caminiti M; Foti R; Riccieri V; Guiducci S; Pellegrini R; Zanatta E; Varcasia G; Olivo D; Gigliotti P; Cuomo G; Murdaca G; Cecchetti R; De Angelis R; Romeo N; Ingegnoli F; Cozzi F; Codullo V; Cavazzana I; Colaci M; Abignano G; et alii...